Streetbeat News

Regulatory

VERO

Venus Concept shares are trading lower after a previous rise on Monday when the company received a medical device license from Health Canada for its Venus Bliss MAX system.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 7:39 pm

EADSY

Airbus is under investigation by UK authorities for potential export control violations involving several of its entities in the UK.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 7:28 pm

IWM

QQQ

July saw a significant market rotation with investors moving towards small-cap stocks, anticipating Federal Reserve interest rate cuts. The iShares Russell 2000 ETF (IWM) had its best monthly performance against the Nasdaq 100 (QQQ) since April 2002, with a 9.2% rally. The Russell 2000 could continue to outperform if the Fed cuts rates as expected.

Portfolio Pulse from Piero Cingari

July 30, 2024 | 7:28 pm

NVO

The FDA has issued a warning about the risks of overdoses and adverse events related to compounded semaglutide injectable products, such as Wegovy and Ozempic, which are not FDA-approved. These errors often result from incorrect dosing by patients and healthcare providers. Novo Nordisk's FDA-approved semaglutide products, including Wegovy, Ozempic, and Rybelsus, are designed to mitigate these risks.

Portfolio Pulse from Vandana Singh

July 30, 2024 | 7:02 pm

BTCUSD

Bitcoin advocate Jeremy Kauffman criticized the 'number go up' culture in the Bitcoin community, arguing that it has driven out advocates of financial privacy and freedom. He believes the issues with Bitcoin are cultural rather than technological or regulatory, and expressed disappointment with Bitcoin's inability to assist in situations like the Canadian truckers' protest. Kauffman suggests that the focus on Bitcoin's monetary value has overshadowed its potential as a free currency.

Portfolio Pulse from Khyathi Dalal

July 30, 2024 | 6:42 pm

ABBV

AZN

BMY

JNJ

Four major pharmaceutical companies, Bristol Myers Squibb, Johnson & Johnson, AbbVie, and AstraZeneca, expect minimal business impact from upcoming Medicare price negotiations despite anticipated price cuts. Executives from these companies shared their perspectives during recent quarterly conference calls, indicating that the price cuts are manageable and in line with expectations.

Portfolio Pulse from Vandana Singh

July 30, 2024 | 6:12 pm

CRWD

DAL

MSFT

Delta Air Lines is seeking damages from CrowdStrike and Microsoft after a major system outage caused by a software update led to significant financial losses and flight cancellations. The incident has prompted an investigation by the Department of Transportation.

Portfolio Pulse from Shivani Kumaresan

July 30, 2024 | 6:05 pm

GOOG

GOOGL

META

VOX

XLC

Meta Platforms, Inc. (NASDAQ:META) has agreed to pay a $1.4 billion settlement to Texas over claims of improperly collecting biometric data. This is the largest state privacy fine ever and will be paid over five years. The news has caused META shares to trade lower.

Portfolio Pulse from Lekha Gupta

July 30, 2024 | 5:51 pm

FXY

YCS

The yen has strengthened following a report indicating that Bank of Japan (BOJ) board members will discuss raising interest rates to 0.25%.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 5:28 pm

VRTX

Vertex Pharmaceuticals announced that the FDA has accepted its New Drug Application for Suzetrigine, a non-opioid pain signal inhibitor for moderate-to-severe acute pain. The FDA has granted priority review with a target action date of January 30, 2025.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 5:14 pm